Inflammatory Biomarkers in Seizure

NCT05556109 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2022-09-27

No results posted yet for this study

Summary

1. Evaluation of the role of TRAIL and MCP-2 in differentiation between epileptic seizure and psychogenic non-epileptic seizure.
2. Possible role to predict the prognosis of patients with epileptic seizure

Conditions

  • Biomarkers in Seizures

Interventions

DIAGNOSTIC_TEST

Inflammatory serum biomarkers

Measuring inflammatory serum biomarkers by ELISA

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-31
Primary Completion
2024-10-31
Completion
2024-11-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05556109 on ClinicalTrials.gov